2938
N. Atsumi et al. / Bioorg. Med. Chem. 10 (2002) 2933–2939
white foam): FAB-MS m/z 901(MH +); 1H NMR
(400 MHz, CDCl3) d 13.3 (br s, 1H), 8.29 (m, 2H), 7.61
(s, 1H), 7.54–7.24 (m, 12H), 6.93 (m, 1H), 6.86–6.84 (m,
4H), 6.28 (dd, 1H, J=6.3, 6.8), 4.55 (m, 1H), 3.79 (m,
8H), 3.50 (m, 1H), 3.38 (m, 1H), 3.31 (d, 1H, J=10.3),
3.17 (d, 1H, J=10.3), 2.34 (ddd, 1H, J=3.9, 6.3, 13.7),
2.26 (m, 1H), 2.03 (m, 1H), 1.72 (m, 1H), 1.71 (s, 3H),
0.86 (s, 9H), 0.05, 0.01(each s, each 3H); 13C NMR
(100 MHz, CDCl3) d 206.91, 179.12, 162.51, 162.13,
161.78, 161.46, 159.44, 158.61, 143.77, 136.70, 135.06,
134.74, 132.34, 130.34, 130.23, 129.96, 129.62, 129.19,
129.02, 128.91, 128.03, 127.88, 127.13, 116.38, 113.19,
113.16, 111.96, 88.24, 87.04, 84.80, 72.74, 64.83, 55.13,
39.87, 36.01, 31.03, 30.95, 30.88, 30.79, 25.52, 17.79,
12.82, ꢁ4.89, ꢁ5.26; HRMS calcd for C48H56F3N4
O8Si: 901.3820. Found: 901.3817.
NH4OH at 55 ꢂC for 16 h, and the released ODN pro-
tected by a DMTr group at the 50-end was chroma-
tographed on a C-18 silica gel column (1 ꢃ 10 cm,
Waters) with a linear gradient of CH3CN (from 0 to
30%) in 0.1M TEAA buffer (pH 7.0). The fractions
were concentrated, and the residue was treated with
aqueous 80% AcOH at room temperature for 20 min,
then the solution was concentrated, and the residue was
coevaporated with H2O. The residue was dissolved in
H2O and the solution was washed with Et2O, then the
H2O layer was concentrated to give a deprotected
ODN. The ODN was further purified by reversed-phase
HPLC, using a J’sphere ODN M80 column (4.6 ꢃ
150 mm, YMC) with a linear gradient of CH3CN (from
10 to 35% over 20 min) in 0.01 M TEAA buffer (pH 7.0)
to give a highly purified ODNs 20 (6), 21 (7), 22 (7), 23
(4), 24 (4), 25 (4), and 26 (2). The yields are indicated in
parentheses as OD units at 260 nm starting from 1 mmol
scale.
N4-Benzoyl-20-deoxy-50-O-dimethoxytrityl-5-methyl-40ꢀ-
C-(2-N-trifluoroacetyl) aminoethylcytidine (10). A solu-
tion of 9 (0.254 g, 0.28 mmol), TBAF (1.0 M in THF,
0.56 mL, 0.56 mmol) in THF (15 mL) was stirred at
room temperature for 4 h. The mixture was evaporated,
and the residue was purified by column chromato-
graphy (SiO2, 20–50% EtOAc in hexane) to give 10
(0.21g, 95% as a white foam): FAB-MS m/z 786
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry
Spectra were obtained on a Voyager Elite reflection
time-of-flight mass spectrometry (PerSeptive Bio-
systems, Inc., Framingham, MA, USA) equipped with a
nitrogen laser (337 nm, 3-ns pulse) in the negative ion
mode. 3-Hydroxypicolinic acid (HPA), dissolved in
H2O to give a saturated solution at room temperature,
was used as the matrix. Time-to-mass conversion was
achieved by calibration by using the peak representing
the C+ cation of the charged derivative to be analyzed.
ODN 20: calculated mass, 5444.1; observed mass,
5446.2. ODN 21: calculated mass, 5444.1; observed
mass, 5445.9. ODN 22: calculated mass, 5444.1;
observed mass, 5444.5. ODN 23: calculated mass,
5487.1; observed mass, 5486.5. ODN 24: calculated
mass, 5530.1; observed mass, 5530.3. ODN 25: calcu-
lated mass, 5573.2; observed mass, 5573.7. ODN 26:
calculated mass, 5616.2; observed mass, 5615.9.
1
(MH+); H NMR (400 MHz, CDCl3) d 13.3 (br s, 1H),
8.25 (m, 2H), 7.69 (s, 1H), 7.60 (br s, 1H), 7.54–6.83 (m,
16H), 6.32 (dd, 1H, J=5.9, 7.3), 4.55 (m, 1H), 3.77 (m,
7H), 3.43–3.33 (m, 2H), 3.29 (t, 2H, J=10.5), 2.51 (ddd,
1H, J=2.9, 5.9, 13.7), 2.43 (m, 1H), 2.10–1.95 (m, 2H),
1.71 (s, 3H); 13C NMR (100 MHz, CDCl3) d 207.29,
179.41, 159.56, 158.65, 157.03, 148.19, 143.86, 136.72,
134.88, 134.79, 132.49, 129.96, 129.81, 129.67, 128.06,
127.98, 127.20, 115.75, 113.27, 112.24, 88.60, 87.39,
84.94, 84.87, 73.54, 73.41, 66.47, 55.27, 55.21, 40.98,
35.75, 30.76, 13.06; HRMS calcd for C42H42F3N4 O8:
787.2955. Found: 787.2969.
N4-Benzoyl-20-deoxy-50-O-dimethoxytrityl-5-methyl-40ꢀ-
C-(2-N-trifluoroacetyl)aminoethylcytidine 30-O-(2-cya-
noethyl) N,N-diisopropylphosphoramidite (11). A solu-
tion of 10 (0.844 g, 1.1 mmol), N,N-diisopropylethylamine
(0.77 mL, 4.4 mmol) and chloro(2-cyanoethoxy)(N,N-
diisopropylamino)phosphine (0.49 mL, 2.2 mmol) in
CH2Cl2 (35 mL) was stirred at room temperature for
10 min. The mixture was partitioned between CHCl3
and aqueous saturated NaHCO3. The organic layer was
washed with H2O and then brine, dried (Na2SO4), and
evaporated. The residue was purified by column
chromatography (a neutralized SiO2, 10–30% EtOAc in
hexane) to give 11 (0.67 g, 62% as a white foam): FAB-
MS m/z 987 (MH+); 31P NMR (202 MHz, CDCl3) d
150.44, 149.92; HRMS calcd for C51H59F3N6O9P:
987.4033. Found: 987.4017.
Thermal denaturation
The solution, that contained the oligodeoxynucleotide
(3 mM) and the target duplex (3 mM) in a buffer of
0.01M sodium cacodylate (pH 7.0) and 0.5 M NaCl,
was heated at 60 ꢂC for 5 min and then cooled gradually
to an appropriate temperature, and used for the thermal
denaturation study. Thermal-induced transitions of
each mixture were monitored at 260 nm on a Beckman
DU 650 spectrophotometer. Sample temperature was
increased 0.5 ꢂC/min.
Partial hydrolysis of ODN with snake venom
phosphodiesterase
Synthesis of ODNs
Each ODN labeled with 32P at the 50-end (5 pmol) was
incubated with snake venom phosphodiesterase
(0.32 mg) in the presence of Torula RNA (0.15 OD units
at 260 nm) in a buffer containing 37.5 mM Tris–HCl
(pH 8.0) and 7.5 mM MgCl2 (total 20 mL) at 37 ꢂC. At
appropriate periods, aliquots of the reaction mixture
were separated and added to a solution of EDTA
ODNs were synthesized on a DNA synthesizer (Applied
Biosystem Model 392) by the phosphoramidite
method.31 The fully protected ODNs were then
deblocked and purified by the same procedure as for the
purification of normal ODNs.35 That is, each ODN
linked to the resin was treated with concentrated